PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious Diseases.\', \'National Centre for Infections in Cancer, and.\', \'Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.\', \'Health Sciences Library, Royal Melbourne Hospital, Parkville, VIC, Australia.\', \'Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia; and.\', \'Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, VIC, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1182/bloodadvances.2021006333
?:doi
?:hasPublicationType
?:journal
  • Blood advances
is ?:pmid of
?:pmid
?:pmid
  • 34852173
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34852173>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34852173>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all